The Pharmacy and Poisons Board has issued a directive to recall all Ranitidine products from the Kenyan market.
Ranitidine is a drug used in management of ulcers. Recently, concerns were raised about the drug which was said to be contaminated with the chemical N-nitrosodimethylamine (NDMA), a potential cancer causing agent in humans.
In a letter by the board’s CEO Dr Siyoi addressed to company pharmacists, the board instructed the importers to carry out a level 2 recall as well as furnish the board with details of all Ranitidine products they had imported into the country.
Here is the statement;